Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSA Failure”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Not applicableStudy completedNCT01366053
What this trial is testing

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists

Who this might be right for
Prostate Cancer
CMX Research 125
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Testing effectiveness (Phase 2)Study completedNCT05407311
What this trial is testing

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 53
Testing effectiveness (Phase 2)Study completedNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Post-approval studies (Phase 4)Looking for participantsNCT07569926
What this trial is testing

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 142
Post-approval studies (Phase 4)Study completedNCT06604442
What this trial is testing

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 62
Testing effectiveness (Phase 2)Study completedNCT01304485
What this trial is testing

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Who this might be right for
Prostate Cancer
Phoenix Molecular Imaging 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Testing effectiveness (Phase 2)Ended earlyNCT00482274
What this trial is testing

Docetaxel in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT00879619
What this trial is testing

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more
John P. Fruehauf 4
Large-scale testing (Phase 3)Study completedNCT04742361
What this trial is testing

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Recurrent
ABX advanced biochemical compounds GmbH 136
Testing effectiveness (Phase 2)Study completedNCT03698370
What this trial is testing

Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaPSA ProgressionRecurrent Prostate Carcinoma
Andrei Iagaru 27
Testing effectiveness (Phase 2)Study completedNCT00669656
What this trial is testing

Herbal Therapy for Treatment of Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Southern California 43
Not applicableLooking for participantsNCT06657131
What this trial is testing

Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer After a Radical TreatmentBiochemical Recurrence of Malignant Neoplasm of ProstateBiochemical Persistence of Prostate Cancer
Heinrich-Heine University, Duesseldorf 250
Testing effectiveness (Phase 2)Study completedNCT05249127
What this trial is testing

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 52
Large-scale testing (Phase 3)Ended earlyNCT03440411
What this trial is testing

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 9
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Not applicableLooking for participantsNCT03920033
What this trial is testing

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy

Who this might be right for
Prostate CancerBiochemical RecurrenceRadiation+5 more
Asan Medical Center 288
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Next Page